Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

FDA approves trade name for Medac's subcutaneous methotrexate

April 16, 2014

Bristol-Myers Squibb discloses novel fibronectin domain-based fusion proteins

April 9, 2014

Cellular Biomedicine initiates phase IIb trial of cell therapy for knee osteoarthritis

April 7, 2014

AbbVie disclose novel glucocorticoid receptor modulators

April 2, 2014

FDA approves Otezla for psoriatic arthritis

March 24, 2014

Merck KGaA presents novel DDR2 inhibitors

March 24, 2014

Pfizer seeks additional indication approval in Japan for Solu-Medrol

March 21, 2014

Merck & Co. presents novel SYK inhibitors for the treatment of rheumatoid arthritis

March 20, 2014

Merck & Co patents new SYK inhibitors

March 19, 2014

Regenerative Sciences' Regenexx-SD stem cell therapy studied for knee osteoarthritis

March 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...